Exelixis (EXEL) News Today → Like Tiny Crypto Retirement Funds (From Crypto 101 Media) (Ad) Free EXEL Stock Alerts $23.17 +0.19 (+0.83%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmerican Century Companies Inc. Purchases 338,021 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 19 at 4:43 AMExelixis, Inc. (NASDAQ:EXEL) Holdings Boosted by Teachers Retirement System of The State of Kentuckymarketbeat.com - March 17 at 5:26 AMExchange Traded Concepts LLC Increases Holdings in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 16 at 7:20 AMExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Meditor Group Ltdmarketbeat.com - March 14 at 11:51 AMRyvu Therapeutics Summarizes 2023 Fiscal Year and Provides Corporate Updatefinanznachrichten.de - March 13 at 10:34 AMPolar Capital Holdings Plc Has $23.31 Million Holdings in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 12 at 10:35 AMExelixis, Inc. (NASDAQ:EXEL) Receives Consensus Rating of "Moderate Buy" from Brokeragesamericanbankingnews.com - March 11 at 4:20 AMExelixis, Inc. (NASDAQ:EXEL) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 11 at 4:19 AMJacobs Levy Equity Management Inc. Lowers Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 10 at 10:59 AM2 Biotech Stocks to Buy Hand Over Fist in Marchfool.com - March 8 at 8:15 AM10 Mid-Cap Stocks with Insider Purchasesfinance.yahoo.com - March 7 at 10:18 AM3 Cutting-Edge Biotech Stocks Sitting on the Brink of Successinvestorplace.com - March 6 at 4:45 PMKrensavage Asset Management LLC Sells 234,552 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 6 at 12:20 PMExelixis, Inc.: Exelixis Earnings: Cabometyx Posts Strong Sales; Early-Stage Pipeline Makes Progressfinance.yahoo.com - March 5 at 5:41 AMAlberta Investment Management Corp Lowers Stake in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 4 at 9:38 AM13D Management LLC Purchases 125,728 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 3 at 12:27 PMNomura Holdings Inc. Purchases Shares of 58,300 Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - March 1 at 7:41 AMIs Now The Time To Put Exelixis (NASDAQ:EXEL) On Your Watchlist?finance.yahoo.com - February 29 at 7:53 PMTeza Capital Management LLC Boosts Stake in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 29 at 9:52 AMQ2 2024 EPS Estimates for Exelixis, Inc. (NASDAQ:EXEL) Increased by Analystmarketbeat.com - February 29 at 8:38 AMZacks Research Weighs in on Exelixis, Inc.'s Q1 2025 Earnings (NASDAQ:EXEL)marketbeat.com - February 28 at 9:56 AMExelixis to Webcast Fireside Chats as Part of Investor Conferences in Marchbusinesswire.com - February 27 at 4:05 PMTrexquant Investment LP Acquires 219,567 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 27 at 9:56 AMStock Offerings Prompt Big Insider Buying247wallst.com - February 27 at 8:45 AMExelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatmentsgurufocus.com - February 27 at 8:00 AMTruist Financial Keeps Their Buy Rating on Exelixis (EXEL)markets.businessinsider.com - February 26 at 6:28 PMMaintaining Buy Rating on Exelixis Amid Patent Litigation and Strong Growth Prospectsmarkets.businessinsider.com - February 23 at 3:29 PMExelixis (NASDAQ:EXEL) Shares Up 4.9% on Insider Buying Activitymarketbeat.com - February 23 at 11:32 AMAround $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buyingmarkets.businessinsider.com - February 23 at 10:28 AMAlgert Global LLC Purchases 33,510 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 23 at 9:27 AMExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Deutsche Bank AGmarketbeat.com - February 22 at 5:33 AM55,866 Shares in Exelixis, Inc. (NASDAQ:EXEL) Purchased by QRG Capital Management Inc.marketbeat.com - February 21 at 7:00 AMModerna (MRNA) Earnings Analysis: Buy or Watch for Gains?stocknews.com - February 20 at 3:01 PMOntario Teachers Pension Plan Board Purchases 174,045 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 20 at 1:28 PMEXEL Aug 2024 27.000 callca.finance.yahoo.com - February 19 at 12:37 PMEXEL Aug 2024 21.000 putca.finance.yahoo.com - February 19 at 12:37 PM2 Stocks Under $30 to Buy and Holdfool.com - February 19 at 12:37 PMPAX Financial Group LLC Acquires New Position in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 19 at 10:19 AM2 Stocks Under $30 to Buy and Holdfool.com - February 19 at 8:00 AMEXEL Jan 2025 32.000 putca.finance.yahoo.com - February 18 at 8:38 PMRafferty Asset Management LLC Lowers Position in Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 18 at 7:28 AMSRPT Feb 2024 115.000 putfinance.yahoo.com - February 14 at 7:46 PMJim Simons Increases Stake in Exelixis Incfinance.yahoo.com - February 14 at 2:45 PMMutual of America Capital Management LLC Sells 29,848 Shares of Exelixis, Inc. (NASDAQ:EXEL)marketbeat.com - February 13 at 7:08 AMExelixis (EXEL) Loses -10.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Cornerfinance.yahoo.com - February 12 at 6:25 PMFY2024 Earnings Estimate for Exelixis, Inc. Issued By William Blair (NASDAQ:EXEL)marketbeat.com - February 12 at 2:54 AMExelixis, Inc. (NASDAQ:EXEL) Stake Lessened by New York State Common Retirement Fundmarketbeat.com - February 11 at 4:51 AMExelixis, Inc. (NASDAQ:EXEL) Shares Sold by Scout Investments Inc.marketbeat.com - February 10 at 10:52 AMDown -10% in 4 Weeks, Here's Why You Should You Buy the Dip in Exelixis (EXEL)finance.yahoo.com - February 9 at 2:03 PMS&P 500 Futures Up in Premarket Trading; Cloudflare, Exelixis Leadbarrons.com - February 9 at 8:58 AM Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address They said crypto was dead. It went up 100X. (Ad)Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years. There are five coins you must take a look at right away. EXEL Media Mentions By Week EXEL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼1.090.62▲Average Medical News Sentiment EXEL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼67▲EXEL Articles Average Week Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Halozyme Therapeutics News Syneos Health News Repligen News Medpace News National Research News Precigen News Luna Innovations News Charles River Laboratories International News Neurocrine Biosciences News CRISPR Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.